Naslov
Innovative therapies redefine treatment goals in multiple sclerosis

Autori
Lazibat, I ; Šamija RK ; Rotim, K.

Izvornik
Acta clinica Croatica (0353-9466) 55 (2016), 1; 125-133

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, stručni

Ključne riječi
Multiple sclerosis – therapy ; Multiple sclerosis, relapsing-remitting – drug therapy ; Immunosuppressive agents – therapeutic use ; Treatment outcome

Sažetak
The treatment of multiple sclerosis (MS) is becoming more complex, especially with the expanding number of available therapies for relapsing forms of MS. Greater understand- ing of the degenerative aspects of MS pathogenesis is redefining treatment goals and creating new treatment strategies. The existing immunomodulation drugs (disease-modifying therapies, DMTs) used in MS treatment have shown only partial benefits in controlling disease progression, primarily by reducing the inflammation component. However, new therapies for MS have been shown to be effective in delaying disease progression by protecting against brain atrophy, which is considered the most important preindicator of future patient disability. The favorable effect on reducing brain atrophy suggests the potential neuroprotective or even neuroregenerative effects of new treatments, marking progress in the treatment of MS.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti

POVEZANOST RADA